Health Canada approves skin cancer device from Sensus

11/27/2012 | (Boston)

Health Canada has given Sensus Healthcare the go-ahead to market its SRT-100 system in that country. The device, tailored for use in hospitals and private physician practices, is designed to treat patients with non-melanoma skin cancer without the need for surgery.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ